After Hours Gainer
VATE Innovate Corp.5.11+0.23+4.7%
After Hours:8.07+2.96 (+57.9%)
MediBeacon Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Globe NewswireFri, 17-Jan 6:18 PM
After Hours Gainer
VATE Innovate Corp.5.11+0.23+4.7%
After Hours:7.18+2.07 (+40.5%)
MediBeacon Transdermal GFR System Receives FDA Approval to Assess Kidney Function
Globe NewswireFri, 17-Jan 6:18 PM
VATE Innovate Corp.5.43+0.34 (+6.7%)
VATE Innovate Corp.0.610.00 (+0.3%)
VATE Innovate Corp.0.74-0.01 (-1.9%)
VATE Innovate Corp.0.80+0.01 (+1.3%)